Captor Capital Sells Orange County Retail Location to MedMen
November 16 2018 - 8:34AM
Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR;
FRANKFURT:NMV; USOTC:NWURF) has signed a
definitive agreement (“the Agreement”) to sell the retail
operations and license for a dispensary location in Santa Ana,
California, through an all-stock transaction with MedMen
Enterprises Inc. (“MedMen”) (CSE: MMEN; OTCQX: MMNFF; FSE: A2JM6N)
valued at approximately US$16 million. The store is currently
MedMen branded and managed.
“Through the sale of this dispensary we have
achieved a strong return on our original investment for our
shareholders,” said Captor Capital CEO, John Zorbas. “With the
completion of this divestment, Captor will continue upon our
strategy of owning and developing a new set of self-operated retail
store brands to support our cultivation, manufacturing, and
distribution operations.”
Upon closing, MedMen will issue approximately
3,740,228 Class B Subordinate Voting shares (the “Shares”) to
Captor Capital. At current market price, the Agreement transaction
is valued at US$16,229,567. The final purchase price is subject to
adjustment for accrued liabilities at the time of closing.
MedMen Chief Executive Officer Adam Bierman and
President Andrew Modlin own a combined 2.8 percent of Captor
Capital. As such, an independent committee of the Board reviewed
and approved the transaction. Cormark Securities provided a
fairness opinion to the Board of Directors of MedMen, stating that
in its opinion, and based upon and subject to the assumptions,
limitations, and qualifications set forth therein, the transaction
is fair, from a financial point of view.
The Agreement is subject to regulatory approvals
by various local and state authorities and other customary closing
conditions. The Company expects the transaction to close within 60
days.
About Captor Capital
Captor Capital Corp. is a Canadian firm focused
on the cannabis sector listed on the Canadian Securities Exchange,
the OTC, and the Frankfurt Stock Exchange. A vertically integrated
cannabis company, Captor provides recreational and medical
marijuana based products to consumers via its leading brands and
dispensary locations.
The company follows a strategy of acquiring
cash flowing established companies and organizations with growth
potential that require capital to scale. Captor currently has a
number of revenue generating cannabis investments including a
wholly owned MedMen branded dispensary in West Hollywood, the CHAI
dispensary in Santa Cruz and Higher Ground in Castroville, CA. The
Company also owns Mellow Extracts, a highly regarded producer of
cannabis extracts based in Costa Mesa, CA. Captor Capital is
currently looking at additional revenue generating investments in
the cannabis space and will be updating the market in due
course.
Contact Gavin Davidson, Communications Captor
Capital Corp. 705.446.6630 gavin@captorcapital.com
Forward-Looking Statements
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS
REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This press release contains or refers to
forward-looking information, and is based on current expectations
that involve a number of business risks and uncertainties. Factors
that could cause actual results to differ materially from any
forward-looking statement include, but are not limited to
availability of investment opportunities, economic circumstances,
market fluctuations and uncertainties, uncertainties relating to
the availability and costs of financing needed in the future,
changes in equity markets, inflation, changes in exchange rates,
and the other risks involved in the investment industry and junior
capital markets. Forward-looking statements are subject to
significant risks and uncertainties, and other factors that could
cause actual results to differ materially from expected results.
Readers should not place undue reliance on forward-looking
statements. These forward-looking statements are made as of the
date hereof and the Company assumes no responsibility to update
them or revise them to reflect new events or circumstances other
than as required by law.
MedMen Enterprises (CSE:MMEN)
Historical Stock Chart
From Oct 2024 to Nov 2024
MedMen Enterprises (CSE:MMEN)
Historical Stock Chart
From Nov 2023 to Nov 2024